SANUWAVE Health (SNWV) Projected to Post Earnings on Thursday

Key Points

• SANUWAVE Health is expected to report results before the market opens on Thursday, March 19, with analysts forecasting $0.17 EPS and $13.226 million in quarterly revenue.
• Shares opened at $22.23 (down ~1%); the company has a market cap of $190.64 million and a low P/E of 2.67, trading below its 50‑day ($26.11) and 200‑day ($31.02) moving averages and near its 52‑week low of $21.76.
• SANUWAVE develops non‑invasive extracorporeal shockwave therapy devices, notably the PACE® system for diabetic foot ulcers and other chronic wound and musculoskeletal indications.

SANUWAVE Health (OTCMKTS:SNWV - Get Free Report) is expected to be issuing its results before the market opens on Thursday, March 19th. Analysts expect the company to announce earnings of $0.17 per share and revenue of $13.2260 million for the quarter.

SANUWAVE Health Trading Down 1.0%

Shares of OTCMKTS:SNWV opened at $22.23 on Thursday. The firm's 50 day moving average is $26.11 and its two-hundred day moving average is $31.02. The firm has a market capitalization of $190.64 million, a P/E ratio of 2.67 and a beta of 1.32. SANUWAVE Health has a 52 week low of $21.76 and a 52 week high of $46.58.

SANUWAVE Health Company Profile

SANUWAVE Health, Inc is a medical technology company focused on the development and commercialization of non‐invasive, extracorporeal shockwave therapy devices. Headquartered in Suwanee, Georgia, the company designs and markets its proprietary Pulse® technology platform, which delivers acoustic shockwaves to stimulate tissue regeneration and repair. SANUWAVE's primary objective is to address chronic and hard-to-heal conditions across wound care and musculoskeletal indications by offering an alternative to surgical intervention.

The company's flagship product, the PACE® (Pulse Activated Cell therapy) system, is intended for the treatment of diabetic foot ulcers and other types of chronic wounds.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.